SEC 13F Intelligence

Carlson Capital, L.P. / CELG

Carlson Capital, L.P.’s Celgene Corp Position

Does Carlson Capital, L.P. own Celgene Corp (CELG)? Not currently — the last reported position was 3.08M shares worth $306M in Q3 2019; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$306M
Q3 2019
Shares
3.08M
% of Portfolio
+5.53%
Quarters Held
3
position exited

Position History CELG

Reported value by quarter
Q1 ’19: $221MQ1 ’19Q2 ’19: $267MQ2 ’19Q3 ’19: $306MQ3 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20193.08M$306M+5.53%
Q2 20192.89M$267M+4.04%
Q1 20192.35M$221M+3.93%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Carlson Capital, L.P.’s full portfolio or all institutional holders of CELG.